These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23775968)

  • 41. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome.
    Muchtar E; Derudas D; Mauermann M; Liewluck T; Dispenzieri A; Kumar SK; Dingli D; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Leung N; Chakraborty R; Gonsalves W; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Kyle RA; Rajkumar SV; Gertz MA
    Mayo Clin Proc; 2016 Oct; 91(10):1354-1361. PubMed ID: 27712634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
    Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
    Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polyclonal Localized Light Chain Amyloidosis-A Distinct Entity?
    Ravindran A; Grogg KL; Domaas DA; Go RS
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):588-592. PubMed ID: 27600986
    [No Abstract]   [Full Text] [Related]  

  • 45. AL amyloidosis associated with IgM monoclonal protein: a distinct clinical entity.
    Palladini G; Russo P; Bosoni T; Sarais G; Lavatelli F; Foli A; Bragotti LZ; Perfetti V; Obici L; Bergesio F; Albertini R; Moratti R; Merlini G
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):80-3. PubMed ID: 19362981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High dose therapy for light chain amyloidosis: can we reduce treatment related mortality further?
    Dimopoulos M; Kastritis E
    Leuk Lymphoma; 2008 Jan; 49(1):4-5. PubMed ID: 18203000
    [No Abstract]   [Full Text] [Related]  

  • 47. [New possibilities of the diagnosis and monitoring of the course of AL-amyloidosis].
    Rameev VV; Kozlovskaia LV; Kogarko IN; Kogarko BS
    Ter Arkh; 2010; 82(6):29-32. PubMed ID: 20731106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis.
    Hayes-Lattin BM; Curtin PT; Fleming WH; Leis JF; Stepan DE; Schubach S; Maziarz RT
    Bone Marrow Transplant; 2002 Sep; 30(5):279-85. PubMed ID: 12209349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac amyloidosis--sustained clinical and free light chain response to low dose thalidomide and corticosteroids.
    Campbell P; Murdock C
    Intern Med J; 2006 Feb; 36(2):137-9. PubMed ID: 16472271
    [No Abstract]   [Full Text] [Related]  

  • 50. Characteristics and long-term outcome of patients with systemic immunoglobulin light-chain amyloidosis.
    Nelson LM; Gustafsson F; Gimsing P
    Acta Haematol; 2015; 133(4):336-46. PubMed ID: 25531398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulin light chain amyloidosis and the kidney.
    Gertz MA; Lacy MQ; Dispenzieri A
    Kidney Int; 2002 Jan; 61(1):1-9. PubMed ID: 11786079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation.
    Dittus C; Uwumugambi N; Sun F; Sloan JM; Sanchorawala V
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1729-1732. PubMed ID: 27296954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recognizing Pinch Purpura as the First Manifestation of Light-chain Amyloidosis.
    Öztürk E; Akay MO; Ferhanoğlu B
    Turk J Haematol; 2018 Aug; 35(3):208-209. PubMed ID: 29553461
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy of haemodiafiltration treatment with PEPA dialysis membranes in plasma free light chain removal in a patient with primary amyloidosis.
    Machiguchi T; Tamura T; Yoshida H
    Nephrol Dial Transplant; 2002 Sep; 17(9):1689-91. PubMed ID: 12198225
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma cell neoplasms, their precursor States, and their prediction of organ damage.
    Comenzo RL
    J Clin Oncol; 2014 Sep; 32(25):2679-82. PubMed ID: 25024079
    [No Abstract]   [Full Text] [Related]  

  • 56. Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients.
    Kumar S; Murray D; Dasari S; Milani P; Barnidge D; Madden B; Kourelis T; Arendt B; Merlini G; Ramirez-Alvarado M; Dispenzieri A
    Leukemia; 2019 Jan; 33(1):254-257. PubMed ID: 29977017
    [No Abstract]   [Full Text] [Related]  

  • 57. Diagnostic accuracy of new indirect ELISAs for free light-chain quantification in fat tissue of patients with AL amyloidosis.
    Eelsing E; Bijzet J; Hazenberg B
    Amyloid; 2017 Mar; 24(sup1):46-47. PubMed ID: 28434310
    [No Abstract]   [Full Text] [Related]  

  • 58. In search of the most effective therapy for light chain amyloidosis.
    Palladini G; Milani P; Merlini G
    Amyloid; 2022 Mar; 29(1):67-68. PubMed ID: 34514923
    [No Abstract]   [Full Text] [Related]  

  • 59. Decreased mean platelet volume in patients with amylodiosis.
    Varol E; Ozaydin M
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):578. PubMed ID: 23288868
    [No Abstract]   [Full Text] [Related]  

  • 60. Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis.
    Bak M; Kim D; Choi JO; Kim K; Kim SJ; Jeon ES
    Front Cardiovasc Med; 2022; 9():904878. PubMed ID: 35811735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.